bovnews18h
Why Did BTIG Research Give Plug Power Inc (PLUG) Stock Neutral Rating?
Plug Power Inc (PLUG) stock saw a modest uptick, ending the day at $2.09 which represents a slight increase of $0.06 or 2.96% from the prior close of $2.03. The stock opened at $2.03 and touched a low ...
Papa John’s International (PZZA) Gets a Hold from BTIG
BTIG analyst Peter Saleh maintained a Hold rating on Papa John’s International (PZZA – Research Report) today. The company’s shares closed ...
BTIG Reaffirms Their Hold Rating on United Therapeutics (UTHR)
BTIG analyst Julian Harrison maintained a Hold rating on United Therapeutics (UTHR – Research Report) on January 21. The company’s shares ...
What Happened?
Shares of aircraft leasing company FTAI Aviation (NASDAQ:FTAI) jumped 8% in the morning session as the stock continued to ...
BTIG cuts Outset Medical target to $3, maintains Buy rating
BTIG analyst Maria Thibault revised the price target for Outset Medical (TASE:PMCN) Inc. (NASDAQ:OM) to $3.00, a decrease ...
bovnews2d
MGM Resorts International (MGM) Stock Rated Buy by BTIG Research
MGM Resorts International (MGM) stock saw a modest uptick, ending the day at $33.35 which represents a slight increase of $0.50 or 1.52% from the prior close of $32.85. The stock opened at $32.99 and ...
BTIG reiterates Buy on FTAI Aviation shares despite short report allegations
BTIG maintained its Buy rating and $190.00 price target for FTAI Aviation (NASDAQ: FTAI), which has demonstrated strong revenue growth of 36.77% over the last twelve months, despite recent challenges ...
BTIG to Donate $1 Million to Los Angeles Wildfire Recovery Efforts
BTIG announced today that it will commit to donating $1 million dollars to wildfire relief and restoration efforts in Los Angeles, California. The funds will be donated to reputable organizations ...
Instacart holds leading edge in grocery delivery category - analysts
Instacart (CART) receives positive analyst coverage as a leader in the grocery delivery category with strong growth prospects ...
Investing14d
BTIG initiates ImmunityBio stock with Buy rating, cites potential of planned/underway studies
On Friday, BTIG initiated coverage on ImmunityBio Inc (NASDAQ:IBRX) with a Buy rating and a price target of $6.00. The firm sees potential in the company's lead product, ANKTIVA, an IL-15 receptor ...
Investing16d
BTIG cuts Jasper Therapeutics price target to $64, maintains Buy
In light of these considerations, Zelin updated BTIG's model to reflect a more moderate differentiation of briquilimab versus barzolvolimab and the decreased likelihood of a Q12W regimen. Despite the ...
Investing16d
BTIG retains Buy rating on Boston Scientific stock post acquisition
On Wednesday, BTIG analyst reaffirmed a Buy rating with a $101.00 price target on Boston Scientific shares (NYSE:BSX), a prominent player in the Healthcare Equipment & Supplies industry with a market ...